Northeast Financial Consultants Inc Gelesis Holdings, Inc. Transaction History

Northeast Financial Consultants Inc

  • $2.16 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$0.08 - $1.34 $29,602 - $495,846
370,035 Added 1480.14%
395,035 $427,000
Q2 2022

Aug 12, 2022
SELL
N/A
-10,000 Reduced 28.57%
25,000 $39,000
Q1 2022

May 12, 2022
BUY
N/A
35,000 New
35,000 $158,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email